TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics.

Gupta, M; Neavin, D; Liu, D; Biernacka, J; Hall-Flavin, D; Bobo, W V; Frye, M A; Skime, M; Jenkins, G D; Batzler, A; Kalari, K; Matson, W; Bhasin, S S; Zhu, H; Mushiroda, T; Nakamura, Y; Kubo, M; Wang, L; Kaddurah-Daouk, R; Weinshilboum, R M

Gupta, M; Neavin, D; Liu, D; Biernacka, J; Hall-Flavin, D; Bobo, W V; Frye, M A; Skime, M; Jenkins, G D; Batzler, A; Kalari, K; Matson, W; Bhasin, S S; Zhu, H; Mushiroda, T; Nakamura, Y; Kubo, M; Wang, L; Kaddurah-Daouk, R; Weinshilboum, R M.

Affiliation

Gupta M; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
Neavin D; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
Liu D; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
Biernacka J; Department of Biomedical Statistics and Bioinformatics - Genetics and Bioinformatics, Mayo Clinic, Rochester, MN, USA.
Hall-Flavin D; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Bobo WV; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Frye MA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Skime M; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Jenkins GD; Department of Biomedical Statistics and Bioinformatics - Genetics and Bioinformatics, Mayo Clinic, Rochester, MN, USA.
Batzler A; Department of Biomedical Statistics and Bioinformatics - Genetics and Bioinformatics, Mayo Clinic, Rochester, MN, USA.
Kalari K; Department of Biomedical Statistics and Bioinformatics - Genetics and Bioinformatics, Mayo Clinic, Rochester, MN, USA.
Matson W; Bedford VA Medical Center, Bedford, MA, USA.
Bhasin SS; Bedford VA Medical Center, Bedford, MA, USA.
Zhu H; Department of Psychiatry and Behavioral Medicine, Duke Institute for Brain Sciences, Duke University, Durham, NC, USA.
Mushiroda T; RIKEN Center for Genomic Medicine, Yokohama, Japan.
Nakamura Y; Department of Medicine, University of Chicago, Chicago, IL, USA.
Kubo M; RIKEN Center for Genomic Medicine, Yokohama, Japan.
Wang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
Kaddurah-Daouk R; Department of Psychiatry and Behavioral Medicine, Duke Institute for Brain Sciences, Duke University, Durham, NC, USA.
Weinshilboum RM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.

Mol Psychiatry ; 21(12): 1717-1725, 2016 12.

Article de En | MEDLINE | ID: mdl-26903268

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pharmacogénétique / Trouble dépressif majeur / Métabolomique Limites: Adult / Female / Humans / Male Langue: En Journal: Mol Psychiatry Sujet du journal: BIOLOGIA MOLECULAR / PSIQUIATRIA Année: 2016 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google